These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27444119)

  • 1. Assessment of plasma acylcarnitines before and after weight loss in obese subjects.
    Schooneman MG; Napolitano A; Houten SM; Ambler GK; Murgatroyd PR; Miller SR; Hollak CE; Tan CY; Virtue S; Vidal-Puig A; Nunez DJ; Soeters MR
    Arch Biochem Biophys; 2016 Sep; 606():73-80. PubMed ID: 27444119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of altered carnitine availability on acylcarnitine metabolism, energy expenditure and glucose tolerance in diet-induced obese mice.
    Schooneman MG; Houtkooper RH; Hollak CE; Wanders RJ; Vaz FM; Soeters MR; Houten SM
    Biochim Biophys Acta; 2016 Aug; 1862(8):1375-82. PubMed ID: 27112275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.
    Zhang J; Light AR; Hoppel CL; Campbell C; Chandler CJ; Burnett DJ; Souza EC; Casazza GA; Hughen RW; Keim NL; Newman JW; Hunter GR; Fernandez JR; Garvey WT; Harper ME; Fiehn O; Adams SH
    Exp Physiol; 2017 Jan; 102(1):48-69. PubMed ID: 27730694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.
    Mihalik SJ; Goodpaster BH; Kelley DE; Chace DH; Vockley J; Toledo FG; DeLany JP
    Obesity (Silver Spring); 2010 Sep; 18(9):1695-700. PubMed ID: 20111019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Palmitoyl-Carnitine (AC16:0) Is a Marker of Increased Postprandial Nonesterified Incomplete Fatty Acid Oxidation Rate in Adults With Type 2 Diabetes.
    Bouchouirab FZ; Fortin M; Noll C; Dubé J; Carpentier AC
    Can J Diabetes; 2018 Aug; 42(4):382-388.e1. PubMed ID: 29129455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle acylcarnitines during short-term fasting in lean healthy men.
    Soeters MR; Sauerwein HP; Duran M; Wanders RJ; Ackermans MT; Fliers E; Houten SM; Serlie MJ
    Clin Sci (Lond); 2009 Apr; 116(7):585-92. PubMed ID: 18945215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gut microbiota and fatty acid metabolism on dyslipidemia following weight-loss diets in women: Results from a randomized controlled trial.
    Ma Y; Sun Y; Sun L; Liu X; Zeng R; Lin X; Li Y
    Clin Nutr; 2021 Nov; 40(11):5511-5520. PubMed ID: 34656033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men.
    Ribel-Madsen A; Ribel-Madsen R; Brøns C; Newgard CB; Vaag AA; Hellgren LI
    Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hormonal effects on carnitine metabolism in thin and obese subjects: responses to somatostatin, glucagon, and insulin.
    Genuth SM; Hoppel CL
    Metabolism; 1981 Apr; 30(4):393-401. PubMed ID: 6111018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.
    Adams SH; Hoppel CL; Lok KH; Zhao L; Wong SW; Minkler PE; Hwang DH; Newman JW; Garvey WT
    J Nutr; 2009 Jun; 139(6):1073-81. PubMed ID: 19369366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss.
    Laferrère B; Reilly D; Arias S; Swerdlow N; Gorroochurn P; Bawa B; Bose M; Teixeira J; Stevens RD; Wenner BR; Bain JR; Muehlbauer MJ; Haqq A; Lien L; Shah SH; Svetkey LP; Newgard CB
    Sci Transl Med; 2011 Apr; 3(80):80re2. PubMed ID: 21525399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced skeletal muscle mitochondrial respiration and improved glucose metabolism in nondiabetic obese women during a very low calorie dietary intervention leading to rapid weight loss.
    Rabøl R; Svendsen PF; Skovbro M; Boushel R; Haugaard SB; Schjerling P; Schrauwen P; Hesselink MK; Nilas L; Madsbad S; Dela F
    Metabolism; 2009 Aug; 58(8):1145-52. PubMed ID: 19454354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV.
    Bailin SS; Jenkins CA; Petucci C; Culver JA; Shepherd BE; Fessel JP; Hulgan T; Koethe JR
    AIDS Res Hum Retroviruses; 2018 Jun; 34(6):536-543. PubMed ID: 29607651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.
    Tong PC; Lee ZS; Sea MM; Chow CC; Ko GT; Chan WB; So WY; Ma RC; Ozaki R; Woo J; Cockram CS; Chan JC
    Arch Intern Med; 2002 Nov; 162(21):2428-35. PubMed ID: 12437401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Acylcarnitines and Amino Acid Levels As an Early Complex Biomarker of Propensity to High-Fat Diet-Induced Obesity in Mice.
    Horakova O; Hansikova J; Bardova K; Gardlo A; Rombaldova M; Kuda O; Rossmeisl M; Kopecky J
    PLoS One; 2016; 11(5):e0155776. PubMed ID: 27183228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women.
    Huffman KM; Shah SH; Stevens RD; Bain JR; Muehlbauer M; Slentz CA; Tanner CJ; Kuchibhatla M; Houmard JA; Newgard CB; Kraus WE
    Diabetes Care; 2009 Sep; 32(9):1678-83. PubMed ID: 19502541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide treatment and acylcarnitine profiles in Egyptian obese insulin-resistant females.
    Hussein NA; Ebied SA; Nour HA; Zaki UK; El-Kotishy SM; Salem TM
    Eur J Pharmacol; 2021 Jan; 891():173668. PubMed ID: 33098833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma acylcarnitines with insulin sensitivity, insulin secretion, and prediabetes in a biracial cohort.
    Owei I; Umekwe N; Stentz F; Wan J; Dagogo-Jack S
    Exp Biol Med (Maywood); 2021 Aug; 246(15):1698-1705. PubMed ID: 33926260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.